Literature DB >> 22383700

Animal models of atherosclerosis.

Godfrey S Getz1, Catherine A Reardon.   

Abstract

Atherosclerosis is a chronic inflammatory disorder that is the underlying cause of most cardiovascular disease. Both cells of the vessel wall and cells of the immune system participate in atherogenesis. This process is heavily influenced by plasma lipoproteins, genetics, and the hemodynamics of the blood flow in the artery. A variety of small and large animal models have been used to study the atherogenic process. No model is ideal as each has its own advantages and limitations with respect to manipulation of the atherogenic process and modeling human atherosclerosis or lipoprotein profile. Useful large animal models include pigs, rabbits, and nonhuman primates. Due in large part to the relative ease of genetic manipulation and the relatively short time frame for the development of atherosclerosis, murine models are currently the most extensively used. Although not all aspects of murine atherosclerosis are identical to humans, studies using murine models have suggested potential biological processes and interactions that underlie this process. As it becomes clear that different factors may influence different stages of lesion development, the use of mouse models with the ability to turn on or delete proteins or cells in tissue specific and temporal manner will be very valuable.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383700      PMCID: PMC3331926          DOI: 10.1161/ATVBAHA.111.237693

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  140 in total

Review 1.  Natural IgM antibodies against oxidation-specific epitopes.

Authors:  Christoph J Binder
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

2.  Apolipoprotein E2 transgenic rabbits. Modulation of the type III hyperlipoproteinemic phenotype by estrogen and occurrence of spontaneous atherosclerosis.

Authors:  Y Huang; S W Schwendner; S C Rall; D A Sanan; R W Mahley
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

3.  Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.

Authors:  Gary Bradshaw; Alejandra Gutierrez; Jon H Miyake; Kimberly R Davis; Andrew C Li; Christopher K Glass; Linda K Curtiss; Roger A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

Review 4.  Atherosclerotic lesions in mouse and man: is it the same disease?

Authors:  Jacob Fog Bentzon; Erling Falk
Journal:  Curr Opin Lipidol       Date:  2010-10       Impact factor: 4.776

5.  Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse.

Authors:  M E Rosenfeld; P Polinsky; R Virmani; K Kauser; G Rubanyi; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-12       Impact factor: 8.311

Review 6.  Macrophages, lipoprotein metabolism, and atherosclerosis: insights from murine bone marrow transplantation studies.

Authors:  M F Linton; S Fazio
Journal:  Curr Opin Lipidol       Date:  1999-04       Impact factor: 4.776

7.  T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse.

Authors:  H M Dansky; S A Charlton; M M Harper; J D Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

8.  Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.

Authors:  David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad
Journal:  Radiology       Date:  2010-07-28       Impact factor: 11.105

9.  Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice.

Authors:  Eugene Trogan; Jonathan E Feig; Snjezana Dogan; George H Rothblat; Véronique Angeli; Frank Tacke; Gwendalyn J Randolph; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-01       Impact factor: 11.205

10.  Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice.

Authors:  B J van Vlijmen; A M van den Maagdenberg; M J Gijbels; H van der Boom; H HogenEsch; R R Frants; M H Hofker; L M Havekes
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more
  201 in total

1.  Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart: IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS.

Authors:  Gunes Bender; Erin E Schexnaydre; Robert C Murphy; Charis Uhlson; Marcia E Newcomer
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

Review 2.  Sex as a Biological Variable in Atherosclerosis.

Authors:  Joshua J Man; Joshua A Beckman; Iris Z Jaffe
Journal:  Circ Res       Date:  2020-04-23       Impact factor: 17.367

3.  Animal models of cardiovascular disease as test beds of bioengineered vascular grafts.

Authors:  Sindhu Row; Daniel D Swartz; Stelios T Andreadis
Journal:  Drug Discov Today Dis Models       Date:  2018-06-18

Review 4.  Closing the 'phenotype gap' in precision medicine: improving what we measure to understand complex disease mechanisms.

Authors:  Calum A MacRae
Journal:  Mamm Genome       Date:  2019-08-19       Impact factor: 2.957

5.  nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe-/- Mice.

Authors:  Tom Lallemand; Myriam Rouahi; Audrey Swiader; Marie-Hélène Grazide; Nancy Geoffre; Paul Alayrac; Emeline Recazens; Agnès Coste; Robert Salvayre; Anne Nègre-Salvayre; Nathalie Augé
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-05-24       Impact factor: 8.311

Review 6.  Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors:  Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

Review 7.  Use and Importance of Nonhuman Primates in Metabolic Disease Research: Current State of the Field.

Authors:  Peter J Havel; Paul Kievit; Anthony G Comuzzie; Andrew A Bremer
Journal:  ILAR J       Date:  2017-12-01

8.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

9.  Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra.

Authors:  Ruud B van Heeswijk; Roberto Colotti; Emeline Darçot; Jean Delacoste; Maxime Pellegrin; Davide Piccini; Diego Hernando
Journal:  Magn Reson Med       Date:  2017-09-01       Impact factor: 4.668

Review 10.  Immunological aspects of atherosclerosis.

Authors:  S Garrido-Urbani; M Meguenani; F Montecucco; B A Imhof
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.